MBX Biosciences, Inc. (MBX) stock
MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$55.94+1.43 (+2.62%)
Close on Nov 13, 2026Market cap $2.69BP/E –Yield –
MBX Biosciences total assets
Total assets on the balance sheet at the end of each period.
MBX Biosciences's total assets was $500.62M at Sep 30, 2026. For fiscal 2025 it was $385.14M, up 43.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $385.14M | +43.4% |
| FY2024 | Dec 31, 2024 | $268.54M | +219.0% |
| FY2023 | Dec 31, 2023 | $84.18M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $500.62M | +25.1% |
| Q2 FY2026 | Jun 30, 2026 | $435.91M | +88.3% |
| Q1 FY2026 | Mar 31, 2026 | $452.70M | +84.1% |
| Q4 FY2025 | Dec 31, 2025 | $385.14M | +43.4% |
| Q3 FY2025 | Sep 30, 2025 | $400.08M | +41.7% |
| Q2 FY2025 | Jun 30, 2025 | $231.52M | +175.0% |
| Q1 FY2025 | Mar 31, 2025 | $245.93M | – |
| Q4 FY2024 | Dec 31, 2024 | $268.54M | – |
| Q3 FY2024 | Sep 30, 2024 | $282.40M | – |
| Q4 FY2023 | Dec 31, 2023 | $84.18M | – |
See a number that looks wrong?